Rappel de Philips HeartStart XL+ Defibrillator

Selon New Zealand Medicines and Medical Devices Safety Authority, ce/cet/cette rappel concerne un dispositif en/au/aux/à New Zealand qui a été fabriqué par Philips Medical Systems (USA).

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    18773
  • Date de mise en oeuvre de l'événement
    2015-07-06
  • Pays de l'événement
  • Source de l'événement
    NZMMDSA
  • URL de la source de l'événement
  • Notes / Alertes
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Notes supplémentaires dans les données
    Recalling Organisation: Philips New Zealand Commercial Limited, Level 3, 123 Carlton Gore Road, Newmarket, AUCKLAND 1023
  • Cause
    Philips has identifed the following xl+ software and hardware issues:, , software:, * the xl+ may fail to complete the power on sequence and continuously reboot., * the xl+ may either fail to power up or may shut down unexpectedly., * the xl+ may have a software version that did not reset a fail-safe monitoring component which could cause a delay of therapy or pacing interruption., * the xl+ may fail to generate verbal prompts in aed mode., , hardware:, * the speaker may fail., * the battery may not seat properly causing the xl+ to shut down unexpectedly or remain powered on and not acknowledge or charge the battery., * the xl+ exceeds the allowable radiated emissions level for class b cispr11., * the xl+ ecg signal from leads could be lost and unrecoverable., * the xl+ spo2 signal may lose communication and cause the device to reboot., * the xl+ battery detection system may be disrupted and cause a false low battery alarm.
  • Action
    Product to be modified

Device

  • Modèle / numéro de série
    Model: 861290, Affected: Serial number ranges: USO1100100 to USD1101095, US11201096 to USD1203968, US11303969 to USD1309471, US11409472 to US61414022
  • Manufacturer

Manufacturer

  • Société-mère du fabricant (2017)
  • Source
    NZMMDSA